Topic

Elaine Quilici is Pharmaceutical Executive's Senior Editor. Email her at equilici@mmh.com

Articles

Deeply shaped by the experiences of his parents and an early charge to help drive social change, Global Blood Therapeutics’ Ted Love comes at sickle cell disease from a place of caring and urges pharma to follow suit to bring justice to all.

Bound By Blood

Julian Upton is Pharmaceutical Executive’s European and Online Editor. He can be reached at 

Kevin Foust, Senior Director of Research & Early Development at Novartis Gene Therapies, talks to Pharm Exec about his involvement in the development of Zolgensma,  the first and only gene therapy approved to treat spinal muscular atrophy (SMA).

Hooked on Gene Therapy: Kevin Foust, Novartis

Samit Hirawat, chief medical officer at Bristol Myers Squibb, talks about his leading role in BMS’ $300M, five-year plan to expand its efforts in health equity and his career-long commitment to putting patients first.

Diversity of Thought in Action

Matt Ros, EVP, chief strategy and business officer of Epizyme, talks to Pharm Exec about his career in oncology and his role in transforming an epigenetics R&D company into a fully integrated commercial business.


Patients as the North Star

's Online and European Editor. He can be reached at jupton@mjhlifesciences.com

Dr. Husseini Manji talks to Pharm Exec about his new role as J&J's Head of Science for Minds and how he hopes to foster new ways to treat dementia and serious mental disorders and provide holistic mental care.

Advancing the Science for Minds: Dr. Husseini Manji, J&J

Angus Grant, Ph.D., Chief Business Executive of BeiGene, talks to Pharm Exec about his role and his vision for the company’s programs in oncology and beyond.

Partnering for the Future: Angus J. Grant, Chief Business Executive, BeiGene 

Anne E. White, president, Lilly Oncology, talks about how the lessons she learned from leading a startup helped her to speed Lilly’s drug development from target identification through successful launch  

Speed and Sensitivity

A glimpse inside the latest turn in Liz Barrett’s influential journey as an oncology executive—this time leaving the confines of big pharma to tackle the innovation void in treating urologic cancers.


Stepping Out in Oncology

Filippo Petti is CEO of Celyad Oncology tells Pharm Exec how the pandemic has affected his role as a US-based CEO to a Belgian company.

Leading On Two Continents through COVID-19: Filippo Petti, Celyad Oncology

EXUMA Biotech's Dr. Greg Frost talks about his work making CAR-T cell therapy readily accessible and affordable.

Expanding Access to CAR-T: Dr. Greg Frost

Patrick Soon-Shiong, the billionaire biotech entrepreneur and owner of NantWorks, a network of health startups, discusses his companies’ COVID-19 vaccine candidate and its “fighting chance” to outsmart the virus’s hidden tricks through merging supercomputing and modernized DNA delivery.

Tackling a ‘Genius Virus’

Former physician and clinical researcher Antony Loebel, now president and CEO of Sunovion Pharmaceuticals, discusses his career-long mission to advance novel treatments for patients suffering from serious and underserved CNS disorders.

Central Focus: Targeting Unmet Need in CNS

Pharm Exec speaks with Arndt Rolfs, CEO and founder of CENTOGENE, who discusses his company’s rise from a small genetic diagnostics startup to a global organization focused on advancing the understanding of the pathophysiology of rare hereditary diseases.

Rare Insights: Arndt Rolfs, CENTOGENE

Pharm Exec presents the diverse stories of 11 rising biopharma managers.

Pharm Exec's Emerging Pharma Leaders 2020

For Sandra Horning, this year's Healthcare Businesswomen’s Association Woman of the Year, harnessing the patient experience has been the driving force in a career-spanning-and service-focused-mission to fight disease and accelerate the delivery of new medicines.

HBA's Woman of the Year 2020: A Motivated Mission

AstraZeneca’s Habib Bennaceur talks about the key transitions in his career-from local to global-and his current role in positioning AZ’s Farxiga as a drug with the potential to impact the lives of both patients with and without type 2 diabetes.


Habib Bennaceur: Following the Science

Banks Bourne of Tanner Pharma Group talks about the organization's role in delivering access initiatives for products not commercially available in many parts of the world.

A Passion for Access: Banks Bourne, Tanner Pharma Group

Philipp Maerz, CEO of Allergopharma talks about how the company has evolved, his recent transition to CEO, and how he plans to expand in the allergy treatment market.

Advancing in Allergy: Philipp Maerz

Rob Biederman, co-CEO of Catalant Technologies, on why biopharma employees should consider a new career path. 

Planning Ahead with Rob Biederman, co-CEO of Catalant Technologies

Veteran pharma leader Jay Galeota shares learnings and perspectives from an off-the-beaten-path career rise-one driven today by a mission to align the industry’s risk-taking approach across the entire drug life cycle.

Executive Profiles